{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:00:02Z","timestamp":1782849602241,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11095-019-2667-7","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:03:32Z","timestamp":1562871812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice"],"prefix":"10.1007","volume":"36","author":[{"given":"Ekta","family":"Kadakia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha","family":"Harpude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Parayath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Bottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-881X","authenticated-orcid":false,"given":"Mansoor","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"4","key":"2667_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016;15(4):275\u201392.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2667_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","volume":"104","author":"DJ Begley","year":"2004","unstructured":"Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. 2004;104(1):29\u201345.","journal-title":"Pharmacol Ther"},{"key":"2667_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S61288","volume":"9","author":"CT Lu","year":"2014","unstructured":"Lu CT, Zhao YZ, Wong HL, Cai J, Peng L, Tian XQ. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine. 2014;9:2241\u201357.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"2667_CR4","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci"},{"issue":"1","key":"2667_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"William M. Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx: 2005;2(1):3\u201314. \n                    https:\/\/www.sciencedirect.com\/journal\/neurorx","journal-title":"NeuroRX"},{"issue":"3","key":"2667_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1359-6446(00)01632-9","volume":"6","author":"H Kusuhara","year":"2001","unstructured":"Kusuhara H, Sugiyama Y. Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (part 1). Drug Discov Today. 2001;6(3):150\u20136.","journal-title":"Drug Discov Today"},{"key":"2667_CR7","doi-asserted-by":"crossref","unstructured":"Loscher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2005;2(1):86\u201398. \n                    https:\/\/www.sciencedirect.com\/journal\/neurorx","DOI":"10.1602\/neurorx.2.1.86"},{"key":"2667_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","volume":"125","author":"DS Miller","year":"2015","unstructured":"Miller DS. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Adv Cancer Res. 2015;125:43\u201370.","journal-title":"Adv Cancer Res"},{"issue":"7","key":"2667_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/09687688.2010.497971","volume":"27","author":"S Ganta","year":"2010","unstructured":"Ganta S, Deshpande D, Korde A, Amiji M. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers. Mol Membr Biol. 2010;27(7):260\u201373.","journal-title":"Mol Membr Biol"},{"key":"2667_CR10","unstructured":"Shah L. Multifunctional Nanoemulsions for systemic delivery of analgesic peptides to the CNS. In. Pharmaceutical Sciences School of Pharmacy: Northeastern University; 2013."},{"issue":"2","key":"2667_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijpharm.2017.05.051","volume":"533","author":"SM Dordevic","year":"2017","unstructured":"Dordevic SM, Santrac A, Cekic ND, Markovic BD, Divovic B, Ilic TM, et al. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: physicochemical and in vivo performances. Int J Pharm. 2017;533(2):421\u201330.","journal-title":"Int J Pharm"},{"issue":"5","key":"2667_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.apsb.2013.08.001","volume":"3","author":"Kandadi Prabhakar","year":"2013","unstructured":"Kandadi Prabhakar SMA, Goparaboina Surender, Veerabrahma Kishan. Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharmaceutica Sinica B, 2013. 2013;3(5):345\u2013353.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"11","key":"2667_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/jphp.12800","volume":"69","author":"SF Tan","year":"2017","unstructured":"Tan SF, Kirby BP, Stanslas J, Basri HB. Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability. J Pharm Pharmacol. 2017;69(11):1447\u201357.","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20132","key":"2667_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","volume":"347","author":"TK Vyas","year":"2008","unstructured":"Vyas TK, Shahiwala A, Amiji MM. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm. 2008;347(1\u20132):93\u2013101.","journal-title":"Int J Pharm"},{"issue":"12","key":"2667_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771\u201385.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2667_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12031-007-0050-3","volume":"33","author":"JA Hamilton","year":"2007","unstructured":"Hamilton JA, Brunaldi K. A model for fatty acid transport into the brain. J Mol Neurosci. 2007;33(1):12\u20137.","journal-title":"J Mol Neurosci"},{"issue":"2\u20133","key":"2667_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1385\/JMN:16:2-3:181","volume":"16","author":"J Edmond","year":"2001","unstructured":"Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci. 2001;16(2\u20133):181\u201393 discussion 215-121.","journal-title":"J Mol Neurosci"},{"key":"2667_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.brainres.2014.11.059","volume":"1597","author":"JJ Liu","year":"2015","unstructured":"Liu JJ, Green P, John Mann J, Rapoport SI, Sublette ME. Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res. 2015;1597:220\u201346.","journal-title":"Brain Res"},{"issue":"3","key":"2667_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejps.2010.12.005","volume":"42","author":"C Navarro","year":"2011","unstructured":"Navarro C, Gonzalez-Alvarez I, Gonzalez-Alvarez M, Manku M, Merino V, Casabo VG, et al. Influence of polyunsaturated fatty acids on cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model. Eur J Pharm Sci. 2011;42(3):290\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"2667_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11095-013-1252-8","volume":"31","author":"L Shah","year":"2014","unstructured":"Shah L, Gattacceca F, Amiji MM. CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation. Pharm Res. 2014;31(5):1315\u201324.","journal-title":"Pharm Res"},{"issue":"2","key":"2667_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/10611860903244199","volume":"18","author":"S Ganta","year":"2010","unstructured":"Ganta S, Sharma P, Paxton JW, Baguley BC, Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. J Drug Target. 2010;18(2):125\u201333.","journal-title":"J Drug Target"},{"issue":"4","key":"2667_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s11095-014-1553-6","volume":"32","author":"S Hak","year":"2015","unstructured":"Hak S, Garaiova Z, Olsen LT, Nilsen AM, de Lange Davies C. The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice. Pharm Res. 2015;32(4):1475\u201385.","journal-title":"Pharm Res"},{"key":"2667_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuroscience.2015.12.045","volume":"316","author":"OZ Chi","year":"2016","unstructured":"Chi OZ, Barsoum S, Vega-Cotto NM, Jacinto E, Liu X, Mellender SJ, et al. Effects of rapamycin on cerebral oxygen supply and consumption during reperfusion after cerebral ischemia. Neuroscience. 2016;316:321\u20137.","journal-title":"Neuroscience."},{"issue":"11","key":"2667_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/cns.12338","volume":"20","author":"H Qi","year":"2014","unstructured":"Qi H, Su FY, Wan S, Chen Y, Cheng YQ, Liu AJ. The antiaging activity and cerebral protection of rapamycin at micro-doses. CNS Neurosci Ther. 2014;20(11):991\u20138.","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"2667_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1471-4159.2011.07262.x","volume":"117","author":"RX Santos","year":"2011","unstructured":"Santos RX, Correia SC, Cardoso S, Carvalho C, Santos MS, Moreira PI. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease. J Neurochem. 2011;117(6):927\u201336.","journal-title":"J Neurochem"},{"issue":"1","key":"2667_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/18715273113126660184","volume":"13","author":"JA Troca-Marin","year":"2014","unstructured":"Troca-Marin JA, Casanas JJ, Benito I, Montesinos ML. The Akt-mTOR pathway in Down's syndrome: the potential use of rapamycin\/rapalogs for treating cognitive deficits. CNS Neurol Disord Drug Targets. 2014;13(1):34\u201340.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2667_CR27","first-page":"40","volume":"36","author":"M Wong","year":"2013","unstructured":"Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biom J. 2013;36(2):40\u201350.","journal-title":"Biom J"},{"issue":"6","key":"2667_CR28","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.3390\/molecules20069496","volume":"20","author":"Y Cho","year":"2015","unstructured":"Cho Y, Ha ES, Baek IH, Kim MS, Cho CW, Hwang SJ. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit(R) e. Molecules. 2015;20(6):9496\u2013509.","journal-title":"Molecules"},{"issue":"5","key":"2667_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00007691-200410000-00001","volume":"26","author":"MF Paine","year":"2004","unstructured":"Paine MF, Leung LY, Watkins PB. New insights into drug absorption: studies with sirolimus. Ther Drug Monit. 2004;26(5):463\u20137.","journal-title":"Ther Drug Monit"},{"issue":"11","key":"2667_CR30","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1023\/A:1011940108365","volume":"15","author":"A Crowe","year":"1998","unstructured":"Crowe A, Lemaire M. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm Res. 1998;15(11):1666\u201372.","journal-title":"Pharm Res"},{"key":"2667_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/978-1-60761-459-3_46","volume":"603","author":"M Korecka","year":"2010","unstructured":"Korecka M, Shaw LM. Quantitation of sirolimus using liquid chromatography-tandem mass spectrometry (LC-MS-MS). Methods Mol Biol. 2010;603:469\u201377.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2667_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","volume":"31","author":"RA Koster","year":"2009","unstructured":"Koster RA, Dijkers EC, Uges DR. Robust, high-throughput LC-MS\/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit. 2009;31(1):116\u201325.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2667_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/FTD.0b013e3181c49a00","volume":"32","author":"A Meinitzer","year":"2010","unstructured":"Meinitzer A, Gartner G, Pilz S, Stettin M. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin a, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin a and everolimus. Ther Drug Monit. 2010;32(1):61\u20136.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"2667_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/FTD.0000000000000006","volume":"36","author":"PE Morgan","year":"2014","unstructured":"Morgan PE, Brown NW, Tredger JM. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS\/MS using an isotopic everolimus internal standard. Ther Drug Monit. 2014;36(3):358\u201365.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2667_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.ftd.0000148451.35811.74","volume":"27","author":"MA Poquette","year":"2005","unstructured":"Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry (LC\/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine. Ther Drug Monit. 2005;27(2):144\u201350.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"2667_CR36","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.4155\/bio.14.43","volume":"6","author":"C Yuan","year":"2014","unstructured":"Yuan C, Payto D, Gabler J, Wang S. A simple and robust LC-MS\/MS method for measuring sirolimus and everolimus in whole blood. Bioanalysis. 2014;6(12):1597\u2013604.","journal-title":"Bioanalysis."},{"issue":"6","key":"2667_CR37","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Z Rankovic","year":"2015","unstructured":"Rankovic Z. CNS drug design: balancing physicochemical properties for optimal brain exposure. J Med Chem. 2015;58(6):2584\u2013608.","journal-title":"J Med Chem"},{"issue":"5","key":"2667_CR38","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/00007890-199311000-00029","volume":"56","author":"R Yatscoff","year":"1993","unstructured":"Yatscoff R, LeGatt D, Keenan R, Chackowsky P. Blood distribution of rapamycin. Transplantation. 1993;56(5):1202\u20136.","journal-title":"Transplantation."},{"issue":"6","key":"2667_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/00007691-199512000-00020","volume":"17","author":"RW Yatscoff","year":"1995","unstructured":"Yatscoff RW, Wang P, Chan K, Hicks D, Zimmerman J. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations. Ther Drug Monit. 1995;17(6):666\u201371.","journal-title":"Ther Drug Monit"},{"issue":"7","key":"2667_CR40","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s11095-017-2158-7","volume":"34","author":"E Kadakia","year":"2017","unstructured":"Kadakia E, Shah L, Amiji MM. Mathematical modeling and experimental validation of Nanoemulsion-based drug transport across cellular barriers. Pharm Res. 2017;34(7):1416\u201327.","journal-title":"Pharm Res"},{"issue":"3","key":"2667_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1208\/s12249-014-0088-9","volume":"15","author":"S Ganta","year":"2014","unstructured":"Ganta S, Talekar M, Singh A, Coleman TP, Amiji MM. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech. 2014;15(3):694\u2013708.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"2667_CR42","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1021\/mp5008376","volume":"12","author":"FG Sunita Yadav","year":"2015","unstructured":"Sunita Yadav FG, Panicucci R, Amiji MM. Comparative biodistribution and pharmacokinetic analysis of cyclosporine-a in the brain upon intranasal or intravenous Administration in an oil-in-Water Nanoemulsion Formulation. Mol Pharm. 2015;12(5):1523\u201333.","journal-title":"Mol Pharm"},{"issue":"4","key":"2667_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11095-018-2349-x","volume":"35","author":"G Ahmad","year":"2018","unstructured":"Ahmad G, Gattacecca F, El Sadda R, Botchkina G, Ojima I, Egan J, et al. Biodistribution and pharmacokinetic evaluations of a novel Taxoid DHA-SBT-1214 in an oil-in-water Nanoemulsion formulation in naive and tumor-bearing mice. Pharm Res. 2018;35(4):91.","journal-title":"Pharm Res"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2667-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2667-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2667-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T23:13:51Z","timestamp":1594336431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2667-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2667"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2667-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"29 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}